13 June 2025 · The intrathecal route is a high-risk route of administration. Incorrect administration of medicines unsafe for this route can result in patient death.
10 June 2025 · Patients with mitochondrial variants have an increased risk of deafness with amikacin, gentamicin, neomycin and tobramycin. Guidance on testing is provided.